Aaron DeWitt

Aaron DeWitt

Auto-generated profile, based on publicly available information

Aaron DeWitt

Children's Hospital of Philadelphia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2020 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
EPErin Pinto
Erin Pinto
YDYoav Dori
Yoav Dori
CSChristopher Smith
Christopher Smith
ADAaron DeWitt
Aaron DeWitt
CWCatherine Williams
Catherine Williams
DTDalal Taha
Dalal Taha

6 July 2022 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
RLRichard P. Lion
Richard P. Lion
MWMelissa M. Winder
Melissa M. Winder
RARambod Amirnovin
Rambod Amirnovin
KFKristi Fogg
Kristi Fogg
RBRebecca Bertrandt
Rebecca Bertrandt
DBDavid K. Bailly
David K. Bailly
Objective: A standardised multi-site approach to manage paediatric post-operative chylothorax does not exist and leads to unnecessary practice variation. The Chylothorax Work Group utilised the Pediatric Critical Care Consortium infrastructure to address this gap.Methods: Over 60 multi-disciplinary providers representing 22 centres convened virtually as a quality initiative to develop an algorithm to manage paediatric post-operative chylothorax. Agreement was objectively quantified for each recommendation in the algorithm by utilising an anonymous survey. “Consensus” was defined as ≥ 80% of responses as “agree” or “strongly agree” to a recommendation. In order to determine if the algorithm recommendations would be correctly interpreted in the clinical environment, we developed ex vivo simulations and surveyed patients who developed the algorithm and patients who did not.Results: The algorithm is intended for all children (80%) by the workgroup (range 81–100%). Ex vivo simulations demonstrated good understanding by developers (range 94–100%) and non-developers (73%–100%).Conclusions: The quality improvement effort represents the first multi-site algorithm for the management of paediatric post-operative chylothorax. The algorithm includes transparent and objective measures of agreement and understanding. Agreement to the algorithm recommendations was >80%, and overall understanding was 94%.

23 March 2022 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
JWJennifer K. Walter
Jennifer K. Walter
DHDouglas Hill
Douglas Hill
WDWilliam A. Drust
William A. Drust
ALAmy Lisanti
Amy Lisanti
ADAaron DeWitt
Aaron DeWitt
CFChris Feudtner
Chris Feudtner

3 February 2026 in Journal of the American Heart Association
Verified
Journal Article
Open access
CMCatherine M. Montgomery
Catherine M. Montgomery
RRRadhika Rastogi
Radhika Rastogi
ADAaron Dewitt
Aaron Dewitt
BKBenjamin W. Kozyak
Benjamin W. Kozyak
LHLynne Ha
Lynne Ha
JEJonathan B. Edelson
Jonathan B. Edelson
Background: In October 2022, our center implemented a standardized program to promote ventricular recovery in pediatric patients supported with durable ventricular assist devices. We report our experience and outcomes. Methods: The initiative consists of 4 core components for all patients with ventricular assist devices: (1) cultural shift: routine assessment for ventricular recovery for possible device explant or, in complex congenital heart disease (CHD), for further surgical palliation; (2) reverse remodeling—use of goal‐directed medical therapy as tolerated; (3) assessment of recovery: stepwise evaluation by echocardiography, exercise testing, and cardiac catheterization; and (4) multidisciplinary review of patients. This retrospective cohort study includes all patients who underwent durable ventricular assist device implantation between October 2022 and October 2024. Patient characteristics and outcomes are described for those explanted for recovery. Results: The cohort included 35 patients, 22 (63%) with Berlin Heart EXCOR and 13 (37%) with HeartMate 3. Indications included cardiomyopathy (60%, n=21), CHD (31%, n=11), coronary pathology (6%, n=2), and myocarditis (3%, n=1). Nine patients underwent explant (26% of all patients, 38% of patients without CHD). No patients with CHD met criteria for recovery. Median age of explanted patients was 1 year (interquartile range, 3 months–10 years), and all were discharged postexplant. Median follow‐up was 10 months (interquartile range, 5.5–20 months). One patient was relisted for transplant; the others remained outpatient with, at worst, mild ventricular dysfunction. Conclusions: A standardized approach to ventricular recovery was associated with explant in 26% of patients, exclusively among those without CHD. Short‐term postexplant outcomes are encouraging, supporting further study in larger cohorts.

1 October 2025 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
YDYoav Dori
Yoav Dori
EPErin Pinto
Erin Pinto
LBLauren Biroc
Lauren Biroc
MGMatthew J. Gillespie
Matthew J. Gillespie
RCRyan Callahan
Ryan Callahan
CSChristopher L. Smith
Christopher L. Smith
BACKGROUND: External drainage of the thoracic duct can temporarily reduce tissue congestion and improve symptoms in patients with heart failure. However, loss of fluid limits the duration of this approach. Here, we report on our initial experience with thoracic duct drainage and autotransfusion in patients with elevated central venous pressure. METHODS: This is a retrospective review of medical records of 8 patients who underwent percutaneous thoracic duct drainage with autotransfusion as part of their medical care. We reviewed clinical and procedural outcomes, laboratory data, and imaging. RESULTS: In 5 (62.5%) patients, central venous pressure was elevated secondary to congenital heart disease, 1 (12.5%) had a lymphatic conduction disorder and trisomy 21, 1 (12.5%) had a lymphatic conduction disorder with Noonan syndrome and congenital heart disease, and 1 (12.5%) patient had severe chronic lung disease due to prematurity. Median central venous pressure was 15.5 mm Hg (range, 12–28), and all patients presented with severe multicompartment lymphatic failure including plastic bronchitis (12.5%), pleural effusions (37.5%), protein-losing enteropathy (62.5%), ascites (75%), and anasarca (100%). Over 7 (87.5%) patients survived to decannulation, and the median duration of autotransfusion was 11.5 days (range, 6–126). There was a significant reduction in creatinine from a median of 0.63 (0.3–2.4) to 0.36 (0.16–0.8) mg/dL ( P =0.017). There was also a significant reduction in weight ( P =0.017) and drainage output ( P =0.017). There were no intraprocedural or autotransfusion-related deaths. CONCLUSIONS: Thoracic duct drainage with autotransfusion can improve fluid status and end-organ function without significant complications and presents a new therapeutic option. Further studies are needed to better define indications for this procedure and long-term outcomes.

23 October 2026 in Journal of the American Heart Association
Verified
Journal Article
Open access
NMNathan D. Markiewitz
Nathan D. Markiewitz
MOMatthew J. O'COnnor
Matthew J. O'COnnor
HLHongyan Liu
Hongyan Liu
CPChristopher Penney
Christopher Penney
ALAvital Ludomirsky
Avital Ludomirsky
JEJonathan B. Edelson
Jonathan B. Edelson
Background: Patients with pediatric heart failure (HF) face significant morbidity and death. However, there are limited data describing neighborhood characteristics in pediatric patients with HF or exploring the relationship of these factors to resource use and clinical outcomes. We used the Child Opportunity Index 3.0 (COI), a composite index of community resources pertinent to child health, to describe neighborhood characteristics for children with HF and identify its associations with in‐hospital death. Methods: This retrospective cohort study used the Pediatric Health Information System, a national administrative database of tertiary care pediatric hospitals. Inpatient encounters between January 2014 and December 2024 for pediatric patients (aged <18 years) with HF and cardiomyopathy were identified using International Classification of Diseases ( ICD ) codes. The primary exposure of interest was the COI, and the primary outcome of interest was in‐hospital death. Mixed logistic regression models were estimated, unadjusted and adjusted for administrative sex, age, race, and primary payor. Results: Our cohort consisted of index HF admissions in 7060 patients. Half of the cohort was in either the very low (n=2034 [29%]) or low (n=1521 [22%]) COI quintile. After adjustment, patients with a very high COI were less likely to experience in‐hospital death than those living in very low COI neighborhoods (odds ratio, 0.73 [95% CI, 0.54–0.99]; P =0.048). Conclusions: A substantial proportion of children admitted with HF have limited neighborhood resources. Those with higher neighborhood resources are more likely to survive to discharge, emphasizing the relationship between environmental factors and clinical outcomes in pediatric HF.